Spruce Biosciences (SPRB) Asset Utilization Ratio (2023 - 2025)
Spruce Biosciences (SPRB) posted quarterly Asset Utilization Ratio of 0.04 for Q3 2025, down 62.88% year-over-year from 0.1 in Q3 2024, and down 22.62% quarter-over-quarter from 0.05 in Q2 2025.
Spruce Biosciences (SPRB) Asset Utilization Ratio (2023 - 2025) Analysis & Trends
Spruce Biosciences (SPRB) has reported Asset Utilization Ratio for 3 consecutive years, with 0.04 the latest figure, recorded in Q3 2025.
- In Q3 2025, Asset Utilization Ratio fell 62.88% year-over-year to 0.04; the TTM figure through Sep 2025 stood at 0.04 (down 62.88% YoY), while the FY2024 annual figure was 0.07, down 38.19% from the prior year.
- Asset Utilization Ratio retreated to 0.04 in Q3 2025 per SPRB's latest filing, from 0.05 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.12 in Q2 2024 and bottomed at 0.02 in Q1 2023.
- Historically, Asset Utilization Ratio has averaged 0.07 across 3 years, with a median of 0.08 in 2025.
- Annual changes were most pronounced in 2024 — Asset Utilization Ratio soared 497.05% — and 2025, when it sank 62.88%.
- Spruce Biosciences' Asset Utilization Ratio stood at 0.09 in 2023, then retreated by 5.14% to 0.09 in 2024, then slumped by 57.8% to 0.04 in 2025.
- Business Quant data shows SPRB's Asset Utilization Ratio at 0.04 in Q3 2025, 0.05 in Q2 2025, and 0.08 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.50 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.12 Bn | 78.12 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.98 Bn | 53.84 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.08 Bn | 36.99 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 0.13 |
| 10 | Spruce Biosciences | 123.45 Mn | 123.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.04 |
| Jun 30, 2025 | 0.05 |
| Mar 31, 2025 | 0.08 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.10 |
| Jun 30, 2024 | 0.12 |
| Mar 31, 2024 | 0.11 |
| Dec 31, 2023 | 0.09 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.02 |